ClinicalTrials.gg
RecruitingNCT07802080KettlebellUpdated Sep 3, 2026

Effects of Kettlebell Swing Training Combined With Breathing Exercises on Respiratory Muscle Strength and Pulmonary Function in Overweight and Obese Young Adults

An interventional study of Kettlebell swing training and Control in Overweight and Obese and Young Adult, sponsored by University of Phayao. Recruiting at 1 site in Thailand. Open to participants aged 18 Years to 25 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-03.

Sponsored by University of Phayao · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years to 25 Years
Sex
All
01

Study summary

Overweight and obesity are associated with impaired breathing mechanics, including reduced chest wall and diaphragmatic movement, decreased respiratory muscle strength and endurance, and inefficient breathing patterns. These changes may adversely affect pulmonary function, autonomic regulation, and physical capacity.

This study aims to compare the effects of kettlebell swing exercise combined with breathing training versus breathing training alone in individuals with overweight or obesity. Outcomes will include respiratory muscle strength, pulmonary function, heart rate variability, and body composition. The findings may help determine whether adding kettlebell swing exercise to breathing training provides additional benefits for respiratory and cardiometabolic health in this population.

Read the detailed description

A total of 40 young adults aged 18-25 years with overweight or obesity (body mass index [BMI] ≥23.0 kg/m²) will be recruited and randomly assigned to one of two groups.

The experimental group will perform kettlebell swing exercise combined with breathing training for 40 minutes per session. The control group will receive breathing training alone for 20 minutes per session. Both groups will participate in their assigned intervention three times per week for 6 weeks.

Outcome measures will include respiratory muscle strength, pulmonary function, heart rate variability (HRV), and body composition.

02

Conditions studied

  • Overweight and Obese
  • Young Adult

Keywords

  • Kettlebell training
  • Respiratory muscle strength
  • Pulmonary Function
  • Overweight and obese
03

In context

Overweight

3,599 studies on the registry are indexed under Overweight; 852 are open to participants now.

This study's planned enrollment of 40 is below the median of 78 across 3,120 interventional studies indexed under Overweight.

Browse Overweight studies →

Lead sponsor

University of Phayao is the lead sponsor of 11 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 25 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Male or female adults aged 18-25 years with a (BMI) of ≥23.0 kg/m².
  • Individuals who are physically inactive or sedentary, defined as exercising fewer than 3 days per week or engaging in less than 150 minutes of exercise per week.
  • Willingness to provide written to participate in the study.

Exclusion criteria

Exclusion Criteria:

  • Presence of bodily pain, particularly in the upper or lower extremities, with a Visual Analogue Scale (VAS) score of >3/10.
  • Musculoskeletal disorders, such as scoliosis.
  • History of neurological disorders, including spinal cord injury, epilepsy, or stroke.
  • History of respiratory or cardiovascular diseases, including hypertension, heart disease, emphysema, asthma, previous lung lobectomy, or lung cancer.
  • History of chronic non-communicable diseases or other systemic disorders, including diabetes mellitus, kidney disease, liver disease, endocrine disorders, or immune system disorders.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Experimental group

    Kettlebell swing training combined with breathing exercises

    Other: Kettlebell swing training

  • Sham comparator
    Control group

    Breathing exercises

    Other: Control

Interventions

  • OtherKettlebell swing training

    Kettlebell swing training combined with breathing exercises, performed three times per week for 40 minutes per session over 6 weeks.

  • OtherControl

    Breathing exercises performed three times per week for 20 minutes per session over 6 weeks.

06

What researchers measure

Primary outcomes

  1. Repiratory muscle strength

    Respiratory muscle strength will be measured using a handheld manometer (MicroRPM). Participants will be instructed to perform a maximal inspiratory effort from residual volume to assess maximal inspiratory pressure (PImax) and a maximal expiratory effort from total lung capacity to assess maximal expiratory pressure (PEmax).

    Time frame: Before and after the 6 week intervention

  2. Heart rate variability (HRV)

    Time and frequency-domain heart rate variability (HRV) parameters will be measured using the SA-3000P analyzer.

    Time frame: Before and after the 6 week intervention

  3. Pulmonary function test

    Vital capacity (VC), expiratory reserve volume (ERV), forced vital capacity (FVC), forced expiratory volume in 1 second (FEV₁), and the FEV₁/FVC ratio will be measured using a portable spirometer.

    Time frame: Before and after the 6 week intervention

Secondary outcomes

  1. Body composition

    Muscle mass and fat mass will be assessed using bioelectrical impedance analysis (BIA).

    Time frame: Before and after the 6 week intervention

07

Study locations

1 of 1 sites recruiting
  • School of Allied Health Sciences, University of Phayao
    Phayao, Changwat Phayao 56000, Thailand
    Recruiting
08

References and documents

Related links

Individual participant data

Plan to share: Undecided — There is currently no finalized plan for sharing de-identified IPD.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 3, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07802080
Lead sponsor
University of Phayao
Responsible party
Pacharee Manoy (Instructor, University of Phayao) — Principal investigator
First posted
Sep 3, 2026
Start date
Sep 1, 2026 (estimated)
Primary completion
Jun 15, 2027 (estimated)
Completion
Jun 20, 2027 (estimated)
Last update
Sep 3, 2026

Study contacts

Pacharee Manoy, Ph.D.
Contact
pachareeman@gmail.com
Thailand: +66 (54) 466 697
Patchareeya Amput, Ph.D.
Contact
patchareeya.am@up.ac.th
Thailand: +66 (54) 466 697

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion